Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Change in Account Payables (2016 - 2025)

Historic Change in Account Payables for Aethlon Medical (AEMD) over the last 15 years, with Q1 2025 value amounting to -$202334.0.

  • Aethlon Medical's Change in Account Payables fell 8459.28% to -$202334.0 in Q1 2025 from the same period last year, while for Mar 2025 it was $33131.0, marking a year-over-year decrease of 9002.72%. This contributed to the annual value of $33131.0 for FY2025, which is 9002.72% down from last year.
  • According to the latest figures from Q1 2025, Aethlon Medical's Change in Account Payables is -$202334.0, which was down 8459.28% from -$229645.0 recorded in Q4 2024.
  • Aethlon Medical's 5-year Change in Account Payables high stood at $406264.0 for Q4 2023, and its period low was -$229645.0 during Q4 2024.
  • Its 5-year average for Change in Account Payables is $26342.3, with a median of $12870.0 in 2022.
  • Its Change in Account Payables has fluctuated over the past 5 years, first tumbled by 277191.92% in 2021, then surged by 305667.44% in 2023.
  • Over the past 5 years, Aethlon Medical's Change in Account Payables (Quarter) stood at -$3832.0 in 2021, then skyrocketed by 435.86% to $12870.0 in 2022, then surged by 3056.67% to $406264.0 in 2023, then tumbled by 156.53% to -$229645.0 in 2024, then grew by 11.89% to -$202334.0 in 2025.
  • Its Change in Account Payables was -$202334.0 in Q1 2025, compared to -$229645.0 in Q4 2024 and $279026.0 in Q3 2024.